Drug Profile
Research programme: antiviral therapeutics - iQur
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator iQur
- Class Viral vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis A; Hepatitis B; Hepatitis C
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-A in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-B in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-C in United Kingdom